Ameritas Investment Partners
TMCI icon

Ameritas Investment Partners’s Treace Medical Concepts TMCI Stock Holding History

Ameritas Investment Partners’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,493
Closed -$6.02K – 3329
2026
Q1 		$6.02K Hold
4,493
– – ﹤0.01% 2961
2025
Q4 		$11K Hold
4,493
– – ﹤0.01% 2885
2025
Q3 		$30.1K Hold
4,493
– – ﹤0.01% 2480
2025
Q2 		$26.4K Hold
4,493
– – ﹤0.01% 2537
2025
Q1 		$37.7K Hold
4,493
– – ﹤0.01% 2270
2024
Q4 		$33.4K Hold
4,493
– – ﹤0.01% 2409
2024
Q3 		$26.1K Hold
4,493
– – ﹤0.01% 2522
2024
Q2 		$29.9K Hold
4,493
– – ﹤0.01% 2428
2024
Q1 		$58.6K Hold
4,493
– – ﹤0.01% 2055
2023
Q4 		$57.3K Hold
4,493
– – ﹤0.01% 2092
2023
Q3 		$58.9K Buy
4,493
+759
+20% +$13.9K ﹤0.01% 1995
2023
Q2 		$95.5K Buy
3,734
+780
+26% +$20.1K ﹤0.01% 1628
2023
Q1 		$74.4K Buy
2,954
+629
+27% +$14.8K ﹤0.01% 1727
2022
Q4 		$60.8K Hold
2,325
– – ﹤0.01% 1930
2022
Q3 		$51K Hold
2,325
– – ﹤0.01% 1966
2022
Q2 		$33K Hold
2,325
– – ﹤0.01% 2266
2022
Q1 		$44K Hold
2,325
– – ﹤0.01% 2134
2021
Q4 		$43K Buy
2,325
+1,468
+171% +$30.3K ﹤0.01% 2223
2021
Q3 		$23K Hold
857
– – ﹤0.01% 2628
2021
Q2 		$27K Buy
+857
New +$27.3K ﹤0.01% 2571

Other funds holding TMCI

Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CIBC Bancorp USA
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ameritas Investment Partners's TMCI Position: Q2 2026 in Review

Ameritas Investment Partners sold out of Treace Medical Concepts (TMCI) in Q2 2026, closing a stake of 4,493 shares — an estimated $6.02K sold.

Ameritas Investment Partners first reported a position in TMCI in Q2 2021 and held it in 20 quarters. The position peaked at $95.5K in Q2 2023. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Ameritas Investment Partners reported no remaining Treace Medical Concepts position as of Q2 2026 after selling out during the quarter.
  • Ameritas Investment Partners sold 4,493 Treace Medical Concepts shares in Q2 2026, an estimated $6.02K.
  • Ameritas Investment Partners first reported a position in Treace Medical Concepts in Q2 2021 and held it in 20 quarters.
  • Ameritas Investment Partners's Treace Medical Concepts position peaked at $95.5K in Q2 2023.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.